Dive Into Dollar Tr...
Health Care: Drugs
Targacept Inc. (TRGT: NASDAQ)
$5.48 0.07 | 1.29%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -7.00M | -8.53M | 10.90M | -39.40M |
| Operating Gains/Losses | -55.00K | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -1.16M | 620.00K | 200.96M | 272.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 2.02M | -443.00K | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -11.52M | 4.42M | -3.80M | 16.51M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 11.97M | 0.00 |
| (Increase) Decrease In Other Working Capital | 440.00K | 5.75M | 0.00 | 473.00K |
| Other Non-Cash Items | -50.12M | -88.93M | -82.33M | -3.93M |
| Net Cash From Continuing Operations | -64.24M | -83.72M | 138.30M | -24.27M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -64.24M | -83.72M | 138.30M | -24.27M |
| Sale of Property, Plant & Equipment | 1.59M | 5.00K | 43.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 159.54M | 100.01M | 84.48M | 41.00M |
| Purchases of Property, Plant & Equipment | -333.00K | -1.43M | -3.31M | -200.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -120.97M | -156.25M | -144.01M | -31.00M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 39.82M | -57.67M | -62.80M | 9.80M |
| Issuance of Debt | 0.00 | 2.13M | 1.23M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 614.00K | 82.65M | 3.29M | 48.57M |
| Repayment of Long-Term Debt | -1.24M | -1.96M | -1.58M | -1.39M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 3.50M | 0.00 |
| Net Cash From Financing Activities | -626.00K | 82.81M | 6.45M | 47.18M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -25.04M | -58.57M | 81.94M | 32.71M |
Portfolios with TRGT
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 29
- Userjobeco
- UserFirstval
- UserGFNN Stockdiagnostics 10
- UserMiriam Hoath
- ContributorStocks Under-$10 Setting Up...
- Contributor10 Biotech Stocks Loved and...
- ContributorHot Biotech Trades for Seco...
- UserMoney
- UserBVF Inc.
Latest TRGT Headlines from TheStreet
- Three Cheers For Alkermes Running A Depression Study In The US of A 04.17.13 | 10:04 am
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- Insider Trading TPCA JCP TRGT GLW 11.20.12 | 10:11 am
- The Targacept Secret That Wall Street Doesn't Want You to Know About 09.18.12 | 07:09 am
- Targacept Stock Hits New 52-Week Low (TRGT) 05.18.12 | 10:05 am
- Targacept Stock Hits New 52-Week Low (TRGT) 04.09.12 | 12:04 pm
- Targacept Stock Gaps Down On Today's Open (TRGT) 03.20.12 | 10:03 am
- Stocks to Watch: Tiffany, Adobe, Targacept (Update 1) 03.20.12 | 08:03 am
Press Releases for TRGT
- Targacept Announces Changes To Board Of Directors And Management - Business Wire 03.18.13 | 04:03 pm
- Targacept And AstraZeneca Amend Collaboration - Business Wire 03.05.13 | 07:03 am
- Targacept To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.26.13 | 08:02 am
- Targacept Reports Fourth Quarter And 2012 Financial Results - Business Wire 02.13.13 | 04:02 pm
- Targacept To Report Fourth Quarter And 2012 Financial Results On February 13, 2013 - Business Wire 02.06.13 | 08:02 am
- Targacept To Present At The 15th Annual BIO CEO & Investor Conference - Business Wire 02.04.13 | 08:02 am
- Targacept To Present At The 2012 Deutsche Bank DbAccess BioFEST - Business Wire 11.27.12 | 08:11 am
- Targacept Appoints Stephen A. Hill, M.D., President And Chief Executive Officer - Business Wire 11.15.12 | 08:11 am
- Targacept Reports Third Quarter 2012 Financial Results - Business Wire 11.06.12 | 04:11 pm
- Targacept To Report Third Quarter 2012 Financial Results On November 6, 2012 - Business Wire 11.01.12 | 08:11 am
Partner Headlines for TRGT
- Targacept Completes Recruitment in Phase 2b Schizophrenia Trial of TC-5619 - Benzinga 04.18.13 | 09:04 am
- 5 Beaten Up Stocks That Insiders Think Can Rebound - Seeking Alpha 04.13.13 | 09:04 am
- Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? - Seeking Alpha 03.15.13 | 09:03 am
- Targacept Says Hill Named CEO - Benzinga 11.15.12 | 08:11 am
- Targacept's ADHDi Candidate Fails - Analyst Blog - NASDAQ 09.20.12 | 10:09 pm
- Targacept's ADHDi Candidate Fails - Analyst Blog - Zacks 09.20.12 | 06:09 pm
- Morning Market Losers - Benzinga 09.17.12 | 09:09 am
- Healthcare Business Review: Vivus DISSED By Citron, Lundbeck, et al Have OPPORTUNITY - Wall St. Cheat Sheet 07.20.12 | 08:07 am
- Why Should You Invest Only in High-Quality Companies? - GuruFocus 06.14.12 | 08:06 pm
- Morning Market Losers - Benzinga 03.20.12 | 09:03 am
